๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Participants With Advanced Solid Tumor Malignancies

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Ann Arbor Incyte Corporation ยท Tests: INCA036873 Study of GS-2426 in Participants With Advanced Solid Tumors NCT07601243Phase 16 sites๐Ÿ“ Boston๐Ÿ“ Grand Rapids๐Ÿ“ East Brunswick Gilead Sciences ยท Tests: GS-2426 An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment NCT06497010EARLY Phase 11 site๐Ÿ“ Guiyang The Affiliated Hospital Of Guizhou Medical University ยท Tests: Biological: PD-1, Biological: InnoPCV A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors NCT05584670Phase 1, Phase 222 sites๐Ÿ“ Newark๐Ÿ“ Iowa City๐Ÿ“ Westwood Sanofi ยท Tests: SAR445877, Cetuximab, ADG126, Bevacizumab, Nivolumab A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors NCT05932862Phase 116 sites๐Ÿ“ Fountain Valley๐Ÿ“ Jacksonville๐Ÿ“ Orlando Exelixis ยท Tests: XL309, Olaparib A Study of HS-20110 in Participants With Advanced Solid Tumors NCT06892379Phase 18 sites๐Ÿ“ Tamarac๐Ÿ“ Fort Wayne๐Ÿ“ Huntersville Hansoh BioMedical R&D Company ยท Tests: HS-20110 (Phase Ia๏ผšDose escalation ), HS-20110 (Phase Ib:Dose expansion ) Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors NCT06974110Phase 115 sites๐Ÿ“ Phoenix๐Ÿ“ San Diego๐Ÿ“ Tampa MOMA Therapeutics ยท Tests: MOMA-341, Irinotecan, Immunotherapy A Study of LY4337713 in Participants With FAP-Positive Solid Tumors NCT07213791Phase 130 sites๐Ÿ“ Newport Beach๐Ÿ“ Stanford๐Ÿ“ Miami Eli Lilly and Company ยท Tests: LY4337713 Study of GV20-0251 in Participants With Solid Tumor Malignancies NCT07070518Phase 1, Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Shanghai GV20 Therapeutics ยท Tests: GV20-0251 Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors NCT06960395Phase 14 sites๐Ÿ“ Scottsdale๐Ÿ“ Houston๐Ÿ“ Wollongong Vir Biotechnology, Inc. ยท Tests: VIR-5525, Pembrolizumab A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors NCT06764771Phase 18 sites๐Ÿ“ Hackensack๐Ÿ“ Allentown๐Ÿ“ Germantown Bristol-Myers Squibb ยท Tests: BMS-986488, Adagrasib, Cetuximab, Nivolumab A Phase 1 Study of D3S-003 as Monotherapy in Participants With Advanced Solid Tumors With a KRAS p.G12D Mutation. NCT07456046Phase 19 sites๐Ÿ“ New Haven๐Ÿ“ Houston๐Ÿ“ San Antonio D3 Bio (Wuxi) Co., Ltd ยท Tests: D3S-003 A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors NCT04895709Phase 1, Phase 247 sites๐Ÿ“ Clovis๐Ÿ“ Los Angeles๐Ÿ“ Newport Beach Bristol-Myers Squibb ยท Tests: BMS-986340, BMS-936558-01, Docetaxel, Pumitamig PRISM-NK: Precision-Matched Allogeneic Single- or Dual-Target CAR-NK Cells for Advanced Solid Tumors NCT07510828Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EB-PT-CAR-NK-S, EB-PT-CAR-NK-D, Lymphodepleting chemotherapy, Cytokine support A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors NCT06440005Phase 17 sites๐Ÿ“ Los Angeles๐Ÿ“ Sarasota๐Ÿ“ St Louis Angiex, Inc. ยท Tests: AGX101 A Study of BG-C477 in Participants With Advanced Solid Tumors NCT06596473Phase 159 sites๐Ÿ“ Goodyear๐Ÿ“ Duarte๐Ÿ“ Aurora BeOne Medicines ยท Tests: BG-C477, Tislelizumab, Chemotherapy An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors NCT06589596Phase 1101 sites๐Ÿ“ Los Alamitos๐Ÿ“ Los Angeles๐Ÿ“ Celebration BeOne Medicines ยท Tests: BGB-58067, BG-89894, Standard of Care Therapy, RAS(ON) Inhibitors Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors NCT06535607Phase 298 sites๐Ÿ“ Los Angeles๐Ÿ“ Baltimore๐Ÿ“ New York AstraZeneca ยท Tests: Volrustomig, Cisplatin, Carboplatin, Paclitaxel, 5-FU A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors NCT06533332Phase 15 sites๐Ÿ“ Ryde๐Ÿ“ Sydney๐Ÿ“ Westmead EtiraRx Australia Pty Ltd ยท Tests: ERX-315 A Study of ASP1002 in Adults for Treatment of Solid Tumors NCT05719558Phase 115 sites๐Ÿ“ New Haven๐Ÿ“ Plainville๐Ÿ“ Gainesville Astellas Pharma Global Development, Inc. ยท Tests: ASP1002, Bevacizumab, Oxaliplatin, Leucovorin, Fluorouracil A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies NCT07231458Phase 15 sites๐Ÿ“ Berlin๐Ÿ“ Tรผbingen๐Ÿ“ Barcelona Abalos Therapeutics GmbH ยท Tests: ABX-001, Pembrolizumab A Study of DS3610a in Participants With Advanced Solid Tumor NCT07159126Phase 14 sites๐Ÿ“ Milwaukee๐Ÿ“ Toulouse๐Ÿ“ Chลซลku Daiichi Sankyo ยท Tests: DS3610a EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors NCT07163325Phase 111 sites๐Ÿ“ Brussels๐Ÿ“ Brussels๐Ÿ“ Ghent Epics Therapeutics ยท Tests: EP102 Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors NCT07299747Phase 1, Phase 21 site๐Ÿ“ Shanghai VelaVigo Bio Inc ยท Tests: VBC103 A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites๐Ÿ“ Grand Rapids๐Ÿ“ St Louis๐Ÿ“ Pittsburgh AstraZeneca ยท Tests: AZD6750, rilvegostomig A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014) NCT07209111Phase 272 sites๐Ÿ“ Baltimore๐Ÿ“ Grand Rapids๐Ÿ“ Las Vegas Merck Sharp & Dohme LLC ยท Tests: Calderasib, Cetuximab A 2-part Phase 1/2 Open-label Trial on ODM-212 NCT07563738Phase 1, Phase 223 sites๐Ÿ“ Los Angeles๐Ÿ“ Orange๐Ÿ“ Fort Worth Orion Corporation, Orion Pharma ยท Tests: ODM-212, Ipilimumab and nivolumab, Gemcitabine and nab-paclitaxel, sotorasib SNV4818 in Participants With Advanced Solid Tumors NCT06736704Phase 1, Phase 212 sites๐Ÿ“ Los Angeles๐Ÿ“ Boston๐Ÿ“ Philadelphia Pikavation Therapeutics, Inc. ยท Tests: SNV4818, Fulvestrant, Palbociclib A Study of MGC028 in Participants With Advanced Solid Tumors NCT06723236Phase 17 sites๐Ÿ“ San Francisco๐Ÿ“ Boston๐Ÿ“ Boston MacroGenics ยท Tests: MGC028 A Phase โ… /โ…กa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors NCT07228247Phase 1, Phase 215 sites๐Ÿ“ Denver๐Ÿ“ Plantation๐Ÿ“ Plantation Hutchmed ยท Tests: HMPL-A251, HMPL-A251
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy